SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.86
arrow_downward
-4.62%(-0.090) 1D
$1.85
arrow_downward
-0.54% (-0.0100)bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.93
High
$2.01
Low
$1.85
Mkt. cap
1.06M
Avg. vol.
133.10K
Volume
84.67K
52-wk high
$16.40
52-wk low
$1.85
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
Open
$1.93
High
$2.01
Low
$1.85
Mkt. cap
1.06M
Avg. vol.
133.10K
Volume
84.67K
52-wk high
$16.40
52-wk low
$1.85
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 month ago
Scinai Immunotherapeutics (SCNI) Edges Higher Amid Tight Trading Range - Gap Fill Strategy
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR